menu
    • menu

    Company profile for Diurnal Group

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2004, Diurnal is a UK-headquartered, European specialty pharma company developing pharmaceutical products for the global market for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine diseas...
    Founded in 2004, Diurnal is a UK-headquartered, European specialty pharma company developing pharmaceutical products for the global market for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Diurnal Groupunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Cardiff Medicentre Heath Park Cardiff, CF14 4UJ
    Telephone
    Telephone
    +44 (0) 29 2068 2069
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.diurnal.co.uk/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Diurnal Presents PIII Extension Study Data for Modified-Release Hydrocortisone
    Diurnal Presents PIII Extension Study Data for Modified-Release Hydrocortisone

    15 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/diurnal-ltd-a-neurocrine-biosciences-company-presents-phase-3-extension-study-data-for-modified-release-hydrocortisone-in-patients-with-congenital-adrenal-hyperplasia-at-endo-2023-301849868.html

    PR NEWSWIRE
    15 Jun 2023
    Share Share
    Amid launch efforts, Neurocrine doles out £48M to acquire UK biotech Diurnal
    Amid launch efforts, Neurocrine doles out £48M to acquire UK biotech Diurnal

    30 Aug 2022

    // Zoey Becker FIERCEPHARMA

    https://www.fiercepharma.com/pharma/neurocrine-biosciences-doles-out-ps483-acquire-diurnal-group

    Zoey Becker FIERCEPHARMA
    30 Aug 2022
    Share Share
    Diurnal shares rocket after knock-out £48mln bid from US biotech
    Diurnal shares rocket after knock-out £48mln bid from US biotech

    29 Aug 2022

    // PROACTIVEINVESTORS

    https://www.proactiveinvestors.com/companies/news/991272/diurnal-shares-rocket-after-knock-out-48mln-bid-from-us-biotech-991272.html

    PROACTIVEINVESTORS
    29 Aug 2022
    Share Share
    EffRx Pharma Signs Exclusive License Agreement With Diurnal
    EffRx Pharma Signs Exclusive License Agreement With Diurnal

    26 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220426005645/en

    BUSINESSWIRE
    26 Apr 2022
    Share Share
    Efmody distribution and marketing agreement signed with EffRx for Switzerland
    Efmody distribution and marketing agreement signed with EffRx for Switzerland

    25 Apr 2022

    // IPGROUPPLC

    https://www.ipgroupplc.com/media/portfolio-news/2022/2022-04-25a

    IPGROUPPLC
    25 Apr 2022
    Share Share
    First adrenal insufficiency patient dosed in Phase 2 study
    First adrenal insufficiency patient dosed in Phase 2 study

    10 Feb 2022

    // PHARMATIMES

    https://www.pharmatimes.com/news/first_adrenal_insufficiency_patient_dosed_in_phase_ii_study_1387551

    PHARMATIMES
    10 Feb 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search